2m 2m 2m 2m 2m 2m 2m
Agios Pharm (AGIO)
NASDAQ
$37.18-$0.005 (-0.01%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.2BMarket Cap
- -10.92%1-Year Change
- BiotechnologyIndustry
Agios Pharm (AGIO)
$37.18-$0.005 (-0.01%)
AGIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $37.18 | ||
Change | +$0.54 (+1.47%) | ||
Open | $36.62 | ||
High | $37.59 | ||
Low | $36.45 | ||
Previous Close | $36.64 | ||
Volume | 849,888 | ||
30-Day Average Volume | 1,213,873 | ||
1-Week Change | 20.05% | ||
1-Month Change | 9.51% | ||
1-Year Change | -10.92% | ||
3-Year Change | 73.90% | ||
5-Year Change | -22.53% | ||
Fundamentals | |||
Shares Outstanding | 59.7M | ||
Total Assets | $1.1B | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.1B | ||
Period: QTR TTM FY | |||
Revenue | $44.7M | ||
Net Income | -$100.7M | ||
Free Cash Flow | -$58.5M | ||
EBIT | -$100.7M | ||
EBITDA | -$99.4M | ||
Net Working Capital | $647.5M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | 47 | ||
P/B | 2 | ||
P/E | -22 | ||
PEG | N/A | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue